Clinical Trial Update: Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and pharmacokinetics of apremilast in recalcitrant plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Psoriasis-Type Psoriasis, Plaque-Type Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2014-10-21